Business, and Liquidity and Going Concern (Details) - USD ($)	3 Months Ended				6 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Business, and Liquidity and Going Concern [Line Items]
Net loss	$ (3,450,256)	$ (3,220,424)	$ (3,112,767)	$ (1,520,534)	$ (6,670,680)	$ (4,633,301)
Accumulated deficit	$ (66,214,815)				(66,214,815)		$ (59,544,135)
Payment of settle agreement					3,500,000
Sorrento Therapeutics, Inc.[Member]
Business, and Liquidity and Going Concern [Line Items]
Payment of settle agreement					$ 6,000,000